Home > Educate > Faculty Publications

Faculty Publications

Latest Publications

CRF faculty members have authored or co-authored chapters in recently published textbooks on cardiovascular medicine.

First Quarter | Second Quarter | Third Quarter | Fourth Quarter
SCAI/ACC i2 | TCT 2008

Publications 2008: First Quarter

  1. Aoki J, Kirtane AJ, Dangas GD, Lansky AJ, Morales A, Kimura M, Kim YH, Moussa I, Weisz G, Kreps EM, Collins M, Frankin-Bond T, Stone GW, Moses JW, Leon MB, Mehran R. Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings.Am J Cardiol. 2008 Jan 1;101(1):58-62. Epub 2007 Nov 26.
  2. Appelbaum E, Kirtane AJ, Clark A, Pride YB, Gelfand EV, Harrigan CJ, Kissinger KV, Manning WJ, Gibson CM. Association of TIMI Myocardial Perfusion Grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction. J Thromb Thrombolysis. 2008 Feb 2 [Epub ahead of print].
  3. De Luca G, Suryapranata H, Stone GW, Marino P. Reply to "Stenting versus plain old angioplasty in patients with ST segment elevation myocardial infarction: Understanding of the randomized trials". Int J Cardiol. 2008 Jan 14 [Epub ahead of print].
  4. Eduardo Missel, Gary S. Mintz, Stephane G. Carlier, Koichi Sano, Jie Qian, Ryan K. Kaple, Celia Castellanos, George Dangas, Roxana Mehran, Jeffrey W. Moses, Gregg W. Stone, Martin B. Leon. Necrotic Core and Its Ratio to Dense Calcium are Predictors of High-Risk Non–ST-Elevation Acute Coronary Syndrome: Corrected Proof, 3 January 2008. Am J Cardiol. DOI: 10.1016/j.amjcard.2007.10.018
  5. Fann JI, Chronos N, Rowe SJ, Michiels R, Lyons BE, Leon MB, Kaplan AV. Evolving strategies for the treatment of valvular heart disease: Preclinical and clinical pathways for percutaneous aortic valve replacement. Catheter Cardiovasc Interv. 2008 Feb 15;71(3):434-440.
  6. Farkouh ME, Dangas G, Leon MB, Smith C, Nesto R, Buse JB, Cohen DJ, Mahoney E, Sleeper L, King S 3rd, Domanski M, McKinlay S, Fuster V. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. Am Heart J. 2008;155:215-223.
  7. Gibson CM, Murphy SA, Pride YB, Kirtane AJ, Aroesty JM, Stein EB, Ciaglo LN, Southard MC, Sabatine MS, Cannon CP, Braunwald E; TIMI Study Group. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study. Am Heart J. 2008 Jan;155(1):133-9. Epub 2007 Nov 19.
  8. Hoffmann R, Morice MC, Moses JW, Fitzgerald PJ, Mauri L, Breithardt G, Schofer J, Serruys PW, Stoll HP, Leon MB. Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials. Heart. 2008 Mar;94(3):322-328. Epub 2007 Aug 29.
  9. Hong MK, Mintz GS, Lee CW, Lee JW, Park JH, Park DW, Lee SW, Kim YH, Cheong SS, Kim JJ, Park SW, Park SJ. A three-vessel virtual histology intravascular ultrasound analysis of frequency and distribution of thin-cap fibroatheromas in patients with acute coronary syndrome or stable angina pectoris. Am J Cardiol. 2008 Mar 1;101(5):568-72. Epub 2007 Dec 21.
  10. Hong MK, Mintz GS, Lee CW, Park DW, Lee SW, Kim YH, Jung IH, Kim SH, Cheong SS, Kim JJ, Park SW, Park SJ. Late target lesion revascularization after implantation of sirolimus-eluting stent. Catheter Cardiovasc Interv. 2008 Feb 15;71(3):299-303.
  11. Iyer SS, White CJ, Hopkins LN, Katzen BT, Safian R, Wholey MH, Gray WA, Ciocca R, Bachinsky WB, Ansel G, Joye JD, Russell ME; BEACH Investigators. Carotid artery revascularization in high-surgical-risk patients using the Carotid WALLSTENT and FilterWire EX/EZ: 1-year outcomes in the BEACH Pivotal Group. J Am Coll Cardiol. 2008 Jan 29;51(4):427-34.
  12. Jensen LO, Thayssen P, Mintz GS, Egede R, Maeng M, Junker A, Galloee A, Christiansen EH, Pedersen KE, Hansen HS, Hansen KN. Comparison of intravascular ultrasound and angiographic assessment of coronary reference segment size in patients with type 2 diabetes mellitus. Am J Cardiol. 2008 Mar 1;101(5):590-5. Epub 2008 Jan 14.
  13. Jeremias A, Ruisi CP, Kirtane AJ, Lee T, Sylvia B, Pinto DS, Ho KK, Cutlip DE, Carrozza JP Jr, Cohen DJ. Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the 'real world'. Coron Artery Dis. 2008 Mar;19:111-115.
  14. Kirtane AJ, Ellis SG, Dawkins KD, Colombo A, Grube E, Popma JJ, Fahy M, Leon MB, Moses JW, Mehran R, Stone GW. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. J Am Coll Cardiol 2008 Feb;51:708-715.
  15. Missel E, Mintz GS, Carlier SG, Sano K, Qian J, Kaple RK, Castellanos C, Dangas G, Mehran R, Moses JW, Stone GW, Leon MB. Necrotic Core and Its Ratio to Dense Calcium Are Predictors of High-Risk Non-ST-Elevation Acute Coronary Syndrome. Am J Cardiol. 2008;101:573-578. Epub 2007 Dec 21.
  16. Park SW, Lee SW, Koo BK, Park DW, Lee SW, Kim YH, Lee CW, Hong MK, Kim JJ, Mori K, Lansky AJ, Mintz GS, Lee MM, Park SJ. Treatment of diffuse IN-stent restenosis with Drug-Eluting stents vs. intracoronary bEta-raDiation therapy: INDEED Study. Int J Cardio.
  17. Pinto DS, Kirtane AJ, Pride YB, Murphy SA, Sabatine MS, Cannon CP, Gibson CM; CLARITY-TIMI 28 Investigators. Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study). Am J Cardiol. 2008 Feb 1;101:303-7. Epub 2007 Dec 20.
  18. Pocock SJ, Lansky AJ, Mehran R, Popma JJ, Fahy MP, Na Y, Dangas G, Moses JW, Pucelikova T, Kandzari DE, Ellis SG, Leon MB, Stone GW. Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. J Am Coll Cardiol. 2008 Jan 1;51(1):23-32.
  19. Pucelikova T, Dangas G, Mehran R Contrast-induced nephropathy. Catheter Cardiovasc Interv. 2008 Jan 1;71(1):62-72.
  20. Pucelikova T, Mehran R, Kirtane AJ, Kim YH, Fahy M, Weisz G, Lansky AJ, Moussa I, Gray WA, Collins MB, Kodali SK, Stone GW, Moses JW, Leon MB, Dangas G. Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era. Am J Cardiol. 2008 Jan 1;101(1):63-8. Epub 2007 Nov 19.
  21. Rhodes JF, Hijazi ZM, Sommer RJ. Pathophysiology of Congenital Heart Disease in the Adult, Part II: Simple Obstructive Lesions. Circulation. 2008 Mar 4;117(9):1228-1237.
  22. Sommer RJ, Hijazi ZM, Rhodes JF Jr. Pathophysiology of congenital heart disease in the adult: part I: Shunt lesions. Circulation. 2008 Feb 26;117(8):1090-1099.
  23. Young JJ, Phillips HR, Marso SP, Granada JF, McPherson JA, Waksman R, Steinhubl SR, Schwartz RS, Stone GW. Vulnerable plaque intervention: State of the art. Catheter Cardiovasc Interv. 2008 Feb 15;71(3):367-74.
  24. Young-Hak Kim, George D. Dangas, Emilia Solinas, Jiro Aoki, Helen Praise, Masashi Kimura, Theresa Franklin-Bond, Neil K. Dasgupta, Ajay J. Kirtane, Issam Moussa, Alexandra J. Lansky, Michael Collins, Gregg W. Stone, Martin B. Leon, Jeffrey W. Moses, Roxana Mehran. Effectiveness of Drug-Eluting Stent Implantation for Patients With Unprotected Left Main Coronary Artery Stenosis. Am J Cardiol; 21 January 2008 (DOI: 10.1016/j.amjcard.2007.10.052)
  25. Ohlmann P, Mintz GS, Kim SW, Pichard AD, Satler LF, Kent KM, Suddath WO, Waksman R, Weissman NJ. Intravascular ultrasound findings in patients with restenosis of sirolimus- and paclitaxel-eluting stents. Int J Cardiol. 2008 Mar 28;125(1):11-5. Epub 2007 Apr 17.
  26. Sommer RJ, Hijazi ZM, Rhodes JF. Pathophysiology of congenital heart disease in the adult: part III: Complex congenital heart disease. Circulation. 2008 Mar 11;117(10):1340-50.
  27. Rinaldi MJ, Kirtane AJ, Piana RN, Caputo RP, Gordon PC, Lopez JJ, Dauerman HL, Ryan TJ Jr, Kiernan FJ, Cutlip DE, Ho KK, Gibson CM, Murphy SA, Cohen DJ. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: Results of a multicenter case-control study with 145 thrombosis events. Am Heart J. 2008 Apr;155(4):654-60. Epub 2008 Feb 21.

back to top

Publications 2008: Second Quarter

  1. Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Mahaffey KW, Cutlip DE, Fitzgerald PJ, Sood P, Su X, Lansky AJ; SPIRIT III Investigators. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA. 2008 Apr 23;299(16):1903-13.
  2. Krucoff MW, Kereiakes DJ, Petersen JL, Mehran R, Hasselblad V, Lansky AJ, Fitzgerald PJ, Garg J, Turco MA, Simonton CA 3rd, Verheye S, Dubois CL, Gammon R, Batchelor WB, O'Shaughnessy CD, Hermiller JB Jr, Schofer J, Buchbinder M, Wijns W; COSTAR II Investigators Group. A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study. J Am Coll Cardiol. 2008 Apr 22;51(16):1543-52.
  3. Feit F, Manoukian SV, Ebrahimi R, Pollack CV, Ohman EM, Attubato MJ, Mehran R, Stone GW. Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol. 2008 Apr 29;51(17):1645-52.
  4. Kimura M, Mintz GS, Weissman NJ, Dawkins KD, Grube E, Ellis SG, Cannon LA, Masud Z, Mandinov L, Baim D, Stone GW. Meta-analysis of the Effects of Paclitaxel-Eluting Stents Versus Bare Metal Stents on Volumetric Intravascular Ultrasound in Patients With Versus Without Diabetes Mellitus. Am J Cardiol. 2008 May 1;101(9):1263-8. Epub 2008 Mar 5.
  5. De Luca G, Suryapranata H, Stone GW, Antoniucci D, Biondi-Zoccai G, Kastrati A, Chiariello M, Marino P. Coronary stenting versus balloon angioplasty for acute myocardial infarction: A meta-regression analysis of randomized trials. Int J Cardiol. 2008 May 7;126(1):37-44. Epub 2007 Jun 4.
  6. Otsuka M, Bruining N, Van Pelt NC, Mollet NR, Ligthart JM, Vourvouri E, Hamers R, De Jaegere P, Wijns W, Van Domburg RT, Stone GW, Veldhof S, Verheye S, Dudek D, Serruys PW, Krestin GP, De Feyter PJ. Quantification of Coronary Plaque by 64-slice Computed Tomography: A Comparison with Quantitative Intracoronary Ultrasound. Invest Radiol. 2008 May;43(5):314-321.
  7. De Luca G, Stone GW, Suryapranata H, Laarman GJ, Menichelli M, Kaiser C, Valgimigli M, Di Lorenzo E, Dirksen MT, Spaulding C, Pittl U, Violini R, Percoco G, Marino P. Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: A meta-analysis of randomized trials. Int J Cardiol. 2008 Apr 2; [Epub ahead of print]
  8. Nikolsky E, Holmes DR, Mehran R, Dangas G, Schampaert E, Morice MC, Schofer J, Sousa JE, Fahy M, Na Y, Donohoe DJ, Moses JW, Leon MB. Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents. Catheter Cardiovasc Interv. 2008 Jun 1;71(7):896-906.
  9. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R; HORIZONS-AMI Trial Investigators. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008 May 22;358(21):2218-30.
  10. Kosmidou I, Karmpaliotis D, Kirtane AJ, Barron HV, Gibson CM. Vascular endothelial growth factors in pulmonary edema: an update. J Thromb Thrombolysis. 2008 Jun;25(3):259-264. Epub 2007 Jun 7.
  11. Pocock SJ, Fahy MP, Mehran R, Stone GW. Reply. J Am Coll Cardiol. 2008 May 20;51(20):1992.
  12. White HD, Chew DP, Hoekstra JW, Miller CD, Pollack CV Jr, Feit F, Lincoff AM, Bertrand M, Pocock S, Ware J, Ohman EM, Mehran R, Stone GW. Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol. 2008 May 6;51(18):1734-41.
  13. Chen SL, Zhang JJ, Ye F, Chen YD, Patel T, Kawajiri K, Lee M, Kwan TW, Mintz G, Tan HC. Study comparing the double kissing (DK) crush with classical crush for the treatment of coronary bifurcation lesions: the DKCRUSH-1 Bifurcation Study with drug-eluting stents. Eur J Clin Invest. 2008 Jun;38(6):361-71.
  14. Gonçalves I, Ares MP, Moberg A, Moses J, To F, Montan J, Pedro LM, Dias N, Fernandes E Fernandes J, Fredrikson GN, Nilsson J, Jovinge S, Bengtsson E. Elastin- and Collagen-Rich Human Carotid Plaques Have Increased Levels of the Cysteine Protease Inhibitor Cystatin C. J Vasc Res. 2008 Mar 28;45(5):395-401. [Epub ahead of print]
  15. Hammerer-Lercher A, Sommer R, Mair J, Tulzer G, Lechner E, Hawa G, Maitzen S, Woloszczuk W, Puschendorf B. N-terminal pro A-type natriuretic peptide but not N-terminal pro C-type natriuretic peptide concentrations are related to cardiac diseases in infants. Clin Chim Acta. 2008 May;391(1-2):118-9. Epub 2008 Jan 30.
  16. Mehran R, Brodie B, Cox DA, Grines CL, Rutherford B, Bhatt DL, Dangas G, Feit F, Ohman EM, Parise H, Fahy M, Lansky AJ, Stone GW. The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. Am Heart J. 2008 Jul;156(1):44-56.
  17. Brar SS, Syros G, Dangas G. Multivessel Disease: Percutaneous Coronary Intervention for Classic Coronary Artery Bypass Grafting Indications. Angiology. 2008 Jun 10. [Epub ahead of print]
  18. Dangas G, Stone GW, Weinberg MD, Webb J, Cox DA, Brodie BR, Krucoff MW, Gibbons RJ, Lansky AJ, Mehran R; EMERALD Investigators. Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial). Am Heart J. 2008 Jun;155(6):1090-6. Epub 2008 Jan 30.
  19. Suzuki K, Saito N, Zhang G, Conditt G, McGregor J, Flynn AM, Leahy D, Glennon P, Leon MB, Hayase M. Development of a novel calcified total occlusion model in porcine coronary arteries. J Invasive Cardiol. 2008 Jun;20(6):296-301.
  20. Gray WA. Clinical trials: past, present, and future. Semin Vasc Surg. 2008 Jun;21(2):80-7.

back to top

Publications 2008: Third Quarter

  1. Kirtane AJ, Leon MB. CABG surgery versus drug-eluting stent implantation in multivessel disease: an interventional cardiology perspective. Nat Clin Pract Cardiovasc Med. 2008 Jul 1. [Epub ahead of print]
  2. Pedersen WR, Block P, Leon M, Kramer P, Kapadia S, Babaliaros V, Kodali S, Tuzcu EM, Feldman T. iCoapsys mitral valve repair system: Percutaneous implantation in an animal model. Catheter Cardiovasc Interv. 2008 Jul 1;72(1):125-31.
  3. Kereiakes DJ, Petersen JL, Batchelor WB, Fitzgerald PJ, Mehran R, Lansky A, Tsujino I, Schofer J, Dubois C, Verheye S, Cristea E, Garg J, Wijns W, Krucoff MW. Clinical and Angiographic Outcomes in Diabetic Patients following Single or Multivessel Stenting in the COSTAR II Randomized Trial. J Invasive Cardiol. 2008 Jul;20(7):335-341
  4. Missel E, Mintz GS, Carlier SG, Qian J, Shan S, Castellanos C, Kaple R, Biro S, Fahy M, Moses JW, Stone GW, Leon MB. In vivo virtual histology intravascular ultrasound correlates of risk factors for sudden coronary death in men: results from the Prospective, multi-centre virtual histology intravascular ultrasound registry. Eur Heart J. 2008 Jul 2. [Epub ahead of print]
  5. Svensson LG, Dewey T, Kapadia S, Roselli EE, Stewart A, Williams M, Anderson WN, Brown D, Leon M, Lytle B, Moses J, Mack M, Tuzcu M, Smith C. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg. 2008 Jul;86(1):46-54; discussion 54-5.
  6. Jensen LO, Maeng M, Mintz GS, Christiansen EH, Hansen KN, Galloe A, Kelbaek H, Hansen HS, Joergensen E, Lassen JF, Thuesen L, Thayssen P. Intravascular ultrasound assessment of expansion of the sirolimus-eluting (cypher select) and Paclitaxel-eluting (taxus express-2) stent in patients with diabetes mellitus. Am J Cardiol. 2008 Jul 1;102(1):19-26. Epub 2008 May 9.
  7. Ellis SG, O'Shaughnessy CD, Martin SL, Kent K, McGarry T, Turco MA, Kereiakes DJ, Popma JJ, Friedman M, Koglin J, Stone GW; TAXUS V ISR Investigators. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial. Eur Heart J. 2008 Jul;29(13):1625-34. Epub 2008 Jun 13.
  8. Solinas E, Dangas G, Kirtane AJ, Lansky AJ, Franklin-Bond T, Boland P, Syros G, Kim YH, Gupta A, Mintz G, Fahy M, Collins M, Kodali S, Stone GW, Moses JW, Leon MB, Mehran R. Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention. Am J Cardiol. 2008 Aug 1;102(3):311-5. Epub 2008 May 24.
  9. White HD, Ohman EM, Lincoff AM, Bertrand ME, Colombo A, McLaurin BT, Cox DA, Pocock SJ, Ware JA, Manoukian SV, Lansky AJ, Mehran R, Moses JW, Stone GW. Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol. 2008 Sep 2;52(10):807-14.
  10. Stettler C, Allemann S, Wandel S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, De Carlo M, Erglis A, Chechi T, Ortolani P, Schalij MJ, Diem P, Meier B, Windecker S, Jüni P. Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ. 2008 Aug 29;337:a1331. doi: 10.1136/bmj.a1331.
  11. Rao SV, Califf RM, Kramer JM, Peterson ED, Gross TP, Pepine CJ, Williams DO, Donohoe D, Waksman R, Mehran R, Krucoff MW. Postmarket evaluation of breakthrough technologies. Am Heart J. 2008 Aug;156(2):201-8.
  12. Hong YJ, Mintz GS, Kim SW, Okabe T, Bui AB, Pichard AD, Satler LF, Waksman R, Weissman NJ. Impact of plaque rupture and elevated C-reactive protein on clinical outcome in patients with acute myocardial infarction: an intravascular ultrasound study. J Invasive Cardiol. 2008 Sep;20(9):428-35.
  13. Mintz GS. Diabetic coronary artery disease: how little we know and how little intravascular ultrasound has taught us. J Am Coll Cardiol. 2008 Jul 22;52(4):263-5.
  14. Grad Y, Sievert H, Nishri B, Stone GW, Katzen BT, Yodfat O, Higashida R, Harris D, Wakhloo AK, Assaf Y, Norbash A, Bushi D, Lieber BB. A Novel Endovascular Device for Emboli Rerouting. Part I: Evaluation in a Swine Model. Stroke. 2008 Aug 14. [Epub ahead of print]
  15. Stone GW. Angioplasty strategies in ST-segment-elevation myocardial infarction: part II: intervention after fibrinolytic therapy, integrated treatment recommendations, and future directions. Circulation. 2008 Jul 29;118(5):552-66.
  16. Stone GW. Angioplasty strategies in ST-segment-elevation myocardial infarction: part I: primary percutaneous coronary intervention. Circulation. 2008 Jul 29;118(5):538-51.
  17. Caixeta A, Weisz G. Restenosis and Gene Polymorphisms. All Humans Are Equal, but Some Humans Are More Equal than Others. Cardiology. 2008 Aug 30;112(4):260-262. [Epub ahead of print].
  18. Kaneda H, Ako J, Terashima M, Morino Y, Honda Y, Yock PG, Leon MB, Moses JW, Fitzgerald PJ; for the SIRIUS Investigators. Sirolimus-eluting stent implantation in small coronary arteries: A three dimensional intravascular ultrasound study from the SIRIUS trial. Int J Cardiol. 2008 Sep 18. [Epub ahead of print]

back to top

Publications 2008: Fourth Quarter

  1. Poston RS, Tran R, Collins M, Reynolds M, Connerney I, Reicher B, Zimrin D, Griffith BP, Bartlett ST. Comparison of economic and patient outcomes with minimally invasive versus traditional off-pump coronary artery bypass grafting techniques. Ann Surg. 2008 Oct;248(4):638-46.
  2. Nikolsky E, Mehran R. Hydration protocols to reduce the incidence of contrast-induced nephropathy. J Invasive Cardiol. 2008 Oct;20(10):527-38.
  3. Kim SW, Mintz GS, Hong YJ, Pakala R, Park KS, Pichard AD, Satler LF, Kent KM, Suddath WO, Waksman R, Weissman NJ. The virtual histology intravascular ultrasound appearance of newly placed drug-eluting stents. Am J Cardiol. 2008 Nov 1;102(9):1182-6. Epub 2008 Jun 12.
  4. Aoki J, Mintz GS, Weissman NJ, Mandinov L, Grube E, Dawkins KD, Ellis SG, Greenberg J, Yu A, Mann JT, Cannon L, Cambier PA, Stone GW. Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials). Am J Cardiol. 2008 Oct 15;102(8):1009-16. Epub 2008 Jul 26.
  5. Okabe T, Weigold WG, Mintz GS, Roswell R, Joshi S, Lee SY, Lee B, Steinberg DH, Roy P, Slottow TL, Smith K, Torguson R, Xue Z, Satler LF, Kent KM, Pichard AD, Weissman NJ, Lindsay J, Waksman R. Comparison of intravascular ultrasound to contrast-enhanced 64-slice computed tomography to assess the significance of angiographically ambiguous coronary narrowings. Am J Cardiol. 2008 Oct 15;102(8):994-1001. Epub 2008 Jul 31.
  6. Reiffel JA. The American journal of cardiology. Demystifying the rate versus rhythm conundrum: new perspectives on recent trials and future treatment options. Introduction. Am J Cardiol. 2008 Sep 22;102(6A):1H-2H.
  7. Reiffel JA. A contemporary look at classic trials in atrial fibrillation: what do they really show and how might they apply to future therapies? Am J Cardiol. 2008 Sep 22;102(6A):3H-11H.
  8. Kadish AH, Reiffel JA, Naccarelli GV, DiMarco JP. Device therapies in the post-myocardial infarction patient with left ventricular dysfunction. Am J Cardiol. 2008 Sep 8;102(5A):29G-37G. Review.
  9. Stone GW, Ellis SG, Colombo A, Grube E, Dawkins KD, Friedman M, Baim DS. Effect of prolonged thienopyridine use after drug-eluting stent implantation (from the TAXUS landmark trials data). Am J Cardiol. 2008 Oct 15;102(8):1017-22. Epub 2008 Jul 25.
  10. White HD, Stone GW; ACUITY Investigators. Reply. J Am Coll Cardiol. 2008 Oct 7;52(15):1278. No abstract available.
  11. Grad Y, Sievert H, Nishri B, Stone GW, Katzen BT, Yodfat O, Higashida R, Harris D, Wakhloo AK, Assaf Y, Norbash A, Bushi D, Lieber BB. A novel endovascular device for emboli rerouting: part I: evaluation in a Swine model. Stroke. 2008 Oct;39(10):2860-6. Epub 2008 Aug 14.

back to top

SCAI/ACC i2 2008

  1. Anemia is associated with increased one-year mortality and ischemic events in patients with acute coronary syndromes: Results from the ACUITY trial. Manoukian SV, Dangas GD, Voeltz MD, Feit F, Mehran R, Stone GW. SCAI/ACC i2.
  2. Major bleeding is associated with increased one-year mortality and ischemic events in patients with acute coronary syndromes: Results from the ACUITY trial. Manoukian SV, Feit F, Steinhubl SR, Voeltz MD, Dangas GD, Ebrahimi R, Mehran R, Stone GW. SCAI/ACC i2.
  3. Transfusion is associated with increased one-year mortality and ischemic events in patients with acute coronary syndromes: Results from the ACUITY trial. Manoukian SV, Voeltz MD, Feit F, Rao SV, Steinhubl SR, Dangas GD, Mehran R, Stone GW. SCAI/ACC i2.
  4. Economic evaluation of bivalirudin with or without glycoprotein IIB/IIIA inhibition versus hepairn with routine glycoprotein IIB/IIIA inhibition for early invasive management of acute coronary symptoms. Pinto DS, Stone GW, York M, Reynolds MR, McLaurin BT, Cox DA, Schneider EA, Shi C, Walczak J, Machon DA, Berezin RH, Mehran R, Ohman EM, Lincoff AM, Cohen DJ. SCAI/ACC i2.
  5. Increased mortality in patients with acute coronary syndromes and delay to angioplasty of greater than 24 hours after hospital admission: An ACUITY substudy. Sorajja P, Gersh BJ, McLaurin BT, Cox DC, Bertrand ME, Lincoff AM, Moses JW, White HD, Pocock SJ, Ware JH, Mehran R, Ohman EM, Stone GW. SCAI/ACC i2.
  6. Is contrast-enhanced 64-slice computed tomography an alternative to quantitative coronary angiography in ambiguous lesions? Okabe T, Weigold WG, Mintz GS, Roswell R, Josh S, Lee SY, Roy P, Steinberg DH, Pinto Slottow TL, Smith KA, Torguson R, Xue Z, Satler LF, Kent KM, Pichard AD, Weissman NJ, Waksman R. SCAI/ACC i2.
  7. Nonuniform struts distribution as the new potential mechanism of stent thrombosis after drug-eluting stent implantation. Opolski MP, Pracon RM, Mintz GS, Okabe T, Pregowski J, Lee SY, van der Waal E, Roy P, Smith KA, Torguson R, Xue Z, Satler LF, Kent KM, Pichard AD, Waksman R, Weissman NJ.SCAI/ACC i2.
  8. Outcome of carotid artery stenting in female versus male patients: A gender analysis of the CAPTURE-2 registry. Arjomand H, Gray W, Hymanson A, Petrovich L, LaBlanc P, Alani F, Surabhi S, Goldberg S, McCormick D. SCAI/ACC i2.
  9. Results from the International Registry of the AngioSculpt Scoring Balloon Catheter for the Treatment of Infra-Popliteal Disease. Kiesz RS, Schinert D, Peeters PJ, Bosiers M, O'Sullivan G, Sultan S, Turco MA, Gray WA, Laird JR, Malik A, Mewissen MW, Dave R, Das TS, Piemonte TC, Khanna P, Gershony G. SCAI/ACC i2.
  10. Clinical and Angiographic Predictors for Successful and Unsuccessful Percutaneous Revascularization of Coronary Chronic Total Occlusions Kotaro Obunai, George D. Dangas, Jeffrey W. Moses, Somjot Brar, Michael B. Collins, Edward M. Kreps, Anuj Gupta, Satya R. Atmakuri, Sudhi Tyagi, Martin B. Leon, Gregg W. Stone, Roxana Mehran, New York Presbyterian-Columbia University Medical Center, New York, NY. SCAI/ACC i2.
  11. Major Adverse Events in STEMI Patients Treated with Primary Angioplasty Occur More Frequently at U.S. Compared with Non U.S. Sites: Analysis from the HORIZONS AMI Trial. Bruce R. Brodie, Thomas Stuckey, Bernhard Witzenbichler, Giulio Guagliumi, Jan Z. Peruga, Dariusz Dudek, Ran Kornowski, Franz Hartmann, George Dangas, S. Chiu Wong, Helen Parise, Roxana Mehran, Gregg W. Stone, LeBauer CV Research Foundation/Moses Cone Hosp., Greensboro, NC, Columbia University Medical Center/Cardiovascular Research Foundation, NY, NY. SCAI/ACC i2.
  12. High-Risk Lipid Profile Is Related to the Ratio of Necrotic Core to Calcification in Human Coronary Arteries: Results From the Prospective, Multicenter VH-IVUS Registry. Eduardo Missel, Gary S. Mintz, Akiko Maehara, Sinan Biro, Celia Castellanos, Ryan K. Kaple, George Dangas, Jeffrey Moses, Gregg W. Stone, Martin B. Leon, Columbia University Medical Center, New York, NY, Cardiovascular Research Foundation, New York, NY. SCAI/ACC i2.
  13. Long Term Adherence to Dual Antiplatelet Therapy and Late Adverse Cardiovascular Events. Somjot S. Brar, Amala Chirumamilla, Roxana Mehran, George Syros, Varinder Singh, Binoy Singh, Gurkan Taviloglu, Laura Higginbotham, Gregg W. Stone, Jeffrey W. Moses, Martin B. Leon, George Dangas, Columbia University, New York, NY, Cardiovascular Research Foundation, New York, NY. SCAI/ACC i2.
  14. The Association of Race/Ethnicity with Contrast Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention. Amala Chirumamilla, Somjot Brar, George Dangas, Vanessa Isiaka, Elene Papakostas, Andy Morales, Theresa Franklin-Bond, Gregg W. Stone, Martin B. Leon, Jeffrey W. Moses, Alexandra Lansky, Roxana Mehran, Columbia University, New York, NY, Cardiovascular Research Foundation, New York, NY. SCAI/ACC i2.
  15. Percent Change in Renal Function After Contrast Exposure is Associated with Long-term Adverse Events in Patients Undergoing Percutaneous Coronary Interventions. Amala Chirumamilla, Somjot S. Brar, George Dangas, Alexandra Lansky, Giora Weisz, Ajay Kirtane, Laura Higginbotham, Theresa Franklin-Bond, Martin B. Leon, Jeffrey W. Moses, Gregg W. Stone, Roxana Mehran, Columbia University, New York, NY, Cardiovascular Research Foundation, New York, NY. SCAI/ACC i2.
  16. A Critical Intravascular Ultrasound Appraisal of the Angiographic Classification of Bifurcation Lesions: Where Is the Plaque Really Located? Carlos R. Oviedo, Akiko Maehara, Gary S. Mintz, Jian Liu, Junqing Yang, Kenichi Tsujita, Takashi Kubo, Hiroshi Doi, Celia Castellanos, Alexandra J. Lansky, Roxana Mehran, George D. Dangas, Jeffrey W. Moses, Martin B. Leon, Gregg W. Stone, Cardiovascular Research Foundation, New York, NY. SCAI/ACC i2.
  17. Safety and effectiveness of bivalirudin compared to either abciximab or eptifibatide in patients with acute myocardial infarction undergoing primary angioplasty: The HORIZONS AMI trial. Giulio Guagliumi, Bernhard Witzenbichler, Jan Peruga, Bruce Brodie, Dariusz Dudek, Ran Kornowski, Janusz Kochman, Yaron Almagor, Dennis Nilsen, Ajay Kirtane, Helen Parise, Roxana Mehran, Gregg W. Stone, Ospedali Riuniti di Bergamo, Bergamo, Italy. SCAI/ACC i2.
  18. The Impact of Mandatory Angiographic Follow-up on the One-Year Clinical and Angiographic Results From Endeavor IV: A Randomized Comparison of the Endeavor Drug (ABT-578) Eluting Stent System vs. Taxus in De Novo Native Coronary Lesions. Martin B. Leon, Jeffrey Popma, Charlie O'Shaunessy, Paul Overlie, Brent McLaurin, Stuart Solomon, Ajay Kirtane, Laura Mauri, Peter Fitzgerald, Kweli Thompson, Columbia University Medical Center, New York, NY. SCAI/ACC i2.
  19. The Fate of Side-Branches Among Patients Treated With Zotarolimus-Eluting and Paclitaxel-Eluting Stents: An ENDEAVOR-IV Substudy. Jeffrey Popma, Ajay Kirtane, Laura Mauri, Martin B. Leon, Kweli Thompson, Columbia University Medical Center, New York, NY, Harvard Clinical Research Institute, Boston, MA. SCAI/ACC i2.
  20. Drug-Eluting Stents Versus Bare-Metal Stents for Transplant Allograft Vasculopathy. LeRoy E. Rabbani, Anuj Gupta, Mark Apfelbaum, Susheel Kodali, Martin Leon, Jeffrey W. Moses, Donna M. Mancini, Columbia University Medical Center, New York, NY. SCAI/ACC i2.
  21. Midterm Clinical Outcomes From the Intravascular Ultrasound Investigation of the Parent Vessel and the Side Branch in Coronary Bifurcation Lesions Treated With Different Stenting Techniques (INSIDE I). Ricardo A. Costa, Shinichi Furuichi, Alexandra J. Lansky, Gary S. Mintz, Mateo Montorfano, Mauro Carlino, Iassen Michev, Flavio Airoldi, Azeem Latib, Giuseppe Sangiogi, Fausto Feres, Rodolfo Staico, Luiz A. Mattos, J. Ribamar Costa, Jr., Antonio Colombo, Centro Cuore Columbus & San Raffaele Ospedale, Milan, Italy, Instituto Dante Pazzanese de Cardiologia / Cardiovascular Research Foundation, Sao Paulo, Brazil. SCAI/ACC i2.
  22. Impact of gender on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: The HORIZONS AMI trial. Liliana Grinfeld, Jorge Belardi, Alexandra Lansky, Bernhard Witzenbichler, Giulio Guagliumi, Krzyszto Zmudka, Martin Mockel, Andrzej Ochala, Witkowski Ruzyllo, Helen Parise, Roxana Mehran, Gregg W. Stone, Trials ArgeNtine Group Organization (TANGO) Coordinating Center, Buenos Aires, Argentina. SCAI/ACC i2.
  23. Gender-Based Evaluation of XIENCE V Everolimus-Eluting Coronary Stent System: Clinical and Angiographic Results From the SPIRIT III Randomized Trial. Alexandra J. Lansky, Mark Midei, William Newman, Mark Sanz, Poornima Sood, Julie Doostzadeh, Xiaolu Su, Sherry Cao, Roseann White, Krishnankutty Sudhir, Gregg W. Stone, Cardiovascular Research Institute, New York, NY. SCAI/ACC i2.
  24. TOPIMAGE Registry Results of Feasibility and Safety of IntraVascular MRI for Measurement of Lipid Fraction Index of Coronary Plaque. Giora Weisz, Martin B. Leon, Horst Sievert, Jeffrey W. Moses, Stefan Verheye, Ruchira Glaser, Ran Kornowaski, Ron Waksman, Evelyn regar, Amir Lerman, David halon, William Wijns, Columbia University Medical Center, New York, NY, Cardiovascular Research Foundation, New York, NY. SCAI/ACC i2.
  25. Safety and Performance of Targeted Renal Therapy: Final Results of The Be-RITe! Registry. Giora Weisz, David E. Allie, Barry S. Weinstock, Mauricio G. Cohen, Dimitris Kyriazis, Craig M. Walker, Jeffrey W. Moses, Paolo Danna, William F. Fearon, Naveen Sachdev, Bret N. Weichmann, Matthew J. Price, Roxana Mehran, Martin B. Leon, Paul S. Teirstein, Columbia University Medical Center, New York, NY, Cardiovascular Research Foundation, New York, NY. SCAI/ACC i2.
  26. Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: The HORIZONS AMI trial. Bernhard Witzenbichler, Giulio Guagliumi, Martin Desaga, Janusz Kochman, Dennis Nilsen, Ariel Finkelstein, Morris Mosseri, Helen Parise, Roxana Mehran, Gregg W. Stone, Columbia University Medical Center/Cardiovascular Research Foundation, New York, NY. SCAI/ACC i2.
  27. Impact of advanced age on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: The HORIZONS AMI trial. Dariusz Dudek, Krzyszto Zmudka, Bernhard Witzenbichler, Giulio Guagliumi, Jan Z. Peruga, Bruce R. Brodie, Ran Kornowski, Franz Hartmann, Martin Mockel, Andrzej Ochala, Helen Parise, Roxana Mehran, Gregg W. Stone, Columbia University Medical Center/Cardiovascular Research Foundation, New York, NY. SCAI/ACC i2.
  28. Comparison of IVUS Findings Between Arterial and Venous Grafts in Patients With Coronary Artery Bypass Surgery. Sung Yun Lee, Gary S. Mintz, Seok-Yeon Kim, Teruo Okabe, Bongryeol Lee, Young Joon Hong, Augusto D. Pichard, Lowell F. Satler, Ron Waksman, Kenneth M. Kent, William O. Suddath, Neil J. Weissman, Cardiovascular Research Institute/Medstar Research Institute, Washington Hospital Center, Washington, DC, Cardiovascular Research Foundation, New York, NY. SCAI/ACC i2.
  29. Clinical, Angiographic and Morphologic Features and Post-PCI Complications in Patients With Acute Coronary Syndromes and Attenuated Plaques Detected by IVUS. Sung Yun Lee, Gary S. Mintz, Seok-Yeon Kim, Teruo Okabe, Young Joon Hong, Augusto D. Pichard, Lowell F. Satler, Ron Waksman, Kenneth M. Kent, William O. Suddath, Neil J. Weissman, Cardiovascular Research Institute/Medstar Research Institute, Washington Hospital Center, Washington, DC, Cardiovascular Research Foundation, New York, NY. SCAI/ACC i2.
  30. The Predictive Value of Computed Tomography Calcium Scores: A Comparison With Quantitative Volumetric Intravascular Ultrasound. Teruo Okabe, Gary S. Mintz, Wm. Guy Weigold, Sung Yun Lee, Probal Roy, Daniel H. Steinberg, Tina L. Pinto Slottow, Kimberly A. Smith, Rebecca Torguson, Zhenyi Xue, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Neil J. Weissman, Joseph Lindsay, Ron Waksman, Washington Hospital Center, Washington, DC, Cardiovascular Research Foundation, New York, NY. SCAI/ACC i2.
  31. Among Serum Lipid Profile Parameters High-Density Lipoprotein Cholesterol Is the Major Determinant of Coronary Plaque Burden: A Volumetric Intravascular Ultrasound Analysis. Eduardo Missel, Gary S. Mintz, Hector Garcia-Garcia, Ryan K. Kaple, Celia Castellanos, Sinan Biro, Jeffrey W. Moses, Gregg W. Stone, Martin B. Leon, Columbia University Medical Center, New York, NY, Cardiovascular Research Foundation, New York, NY. SCAI/ACC i2.
  32. Virtual Histology Intravascular Ultrasound Analysis of Thin-Capped and Thick-Capped Fibroatheromas in Autopsied Coronary Arteries. Sang-Wook Kim, Gary S. Mintz, Wang-Soo Lee, Hyoung-Joong Kim, Eon-Sub Park, Tae-Jin Lee, Bo-Mi Son, Sung-Yun Lee, Gi Hwan Kim, Soon-Auck Hong, Soo-Hee Choi, Kwang-Je Lee, Tae-Ho Kim, Chee-Jeong Kim, Wang-Seong Ryu, Neil J. Weissman, Chung-Ang University Hospital, Seoul, South Korea, Washington Hospital Center, Washington, DC. SCAI/ACC i2.
  33. Quality of Life Improvements Following Transcatheter Aortic Valve Replacement: Results From the REVIVAL II Feasibility Study. Matthew R. Reynolds, Jeffrey W. Moses, Lars G. Svensson, Joshua Walczak, Ronna Berezin, David J. Cohen, for the REVIVAL II Investigators, Beth Israel Deaconess Medical Center, Boston, MA, Mid-America Heart Institute, Kansas City, MO. SCAI/ACC i2.
  34. Incidence and Short-Term Outcomes of Drug-Eluting Stent Fracture in Chronic Total Occlusions: Analysis From the ACROSS-Cypher Trial. Sunil V. Rao, David E. Kandzari, Kelley A. Ryan, Jyotsna Garg, Christopher E. Buller, Bradley H. Strauss, Michael J. Kutryk, Jeffrey W. Moses, Vladimir Dzavik, G.B. John Mancini, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC. SCAI/ACC i2.
  35. Eight-Month Volumetric IVUS Analysis in DM and Non-DM Patients Treated With XIENCE V Everolimus-Eluting Coronary Stent. TAKAO SHIMOHAMA, Junya Ako, Masao Yamasaki, Ichizo Tsujino, Ali H.M. Hassan, Takao Hasegawa, Ryota Sakurai, Katsuhisa Waseda, Paul G. Yock, Yasuhiro Honda, Krishnankutty Sudhir, Gregg W. Stone, Peter J. Fitzgerald, Stanford University Medical Center, Stanford, CA. SCAI/ACC i2.
  36. Characterization of Target Lesion Revascularization After TAXUS Express Paclitaxel-Eluting Stent Implantation. Stephen G. Ellis, Antonio Colombo, Berhard Grube, Gregg W. Stone, Mark Friedman, Donald S. Baim, The Cleveland Clinic Foundation, Cleveland, OH. SCAI/ACC i2.
  37. Is Diabetes A Risk Factyor for Restenosis and Adverse Clinical Outcomes After Paclitaxel-Eluting Stent Implantation? Pooled Analysis of the TAXUS IV and TAXUS V Trials. Gregg W. Stone, Stephen G. Ellis, James B. Hermiller, Jeffrey J. Popma, Neil J. Weissman, Lazar Mandinov, Donald S. Baim, Columbia University Medical Center, New York, NY. SCAI/ACC i2.
  38. Are DES Beneficial in Large Vessels Compared to BMS?: Data from the TAXUS IV and V Randomized Clinical Trials. David A. Cox, James Hermiller, Louis Cannon, Charles O'Shaughnessy, J. Tift Mann, Mark Turco, J. Greenberg, Tom Maloney, Martin Fahey, Stephen Ellis, Gregg W. Stone, Lehigh Valley Hospital, Allentown, PA, Cardiovascular Research Foundation, Columbia University Medical Center, New York, NY. SCAI/ACC i2.
  39. Randomized, Multi-Center Evaluation of the Pimecrolimus-Eluting and the Dual Pimecrolimus/Paclitaxel-Eluting Coronary Stent System in Patients with De Novo Lesions of the Native Coronary Arteries: GENESIS Trial 6 Month Results. Keith D. Dawkins, Stefan Verheye, Joseph Dens, Wolfgang Rutsch, Didier Carrie, Chaim Lotan, Christoph Dubois, Alexandra Lansky, Louise Gambone, Vicki Hacker, Southampton University Hospital, Southampton, United Kingdom, Antwerp Cardiovascular Center Middelheim, Antwerp, Belgium. SCAI/ACC i2.
  40. One Year Clinical and Angiographic Results in Diabetics from ENDEAVOR IV: A Randomized Comparison of the ENDEAVOR Drug (ABT-578) Eluting Stent System Versus TAXUS in De Novo Native Coronary Lesions. Martin B. Leon, Lara Mauri, Charles O'Shaunessy, Paul Overlie, Ajay Kirtane, Jeffrey Popma, Peter Fitzgerald, Colubmia University Medical Center, New York, NY. SCAI/ACC i2.
  41. Clinical and Angiographic Outcomes with Sirolimus-Eluting Stents in Total Coronary Occlusions: ACROSS/TOSCA-4 Trial. David E. Kandzari, Sunil V. Rao, Jeffrey W. Moses, Vladimir Dzavik, Bradley H. Strauss, Michael J. Kutryk, Charles A. Simonton, III, Jyotsna Garg, G.B. John Mancini, Christopher E. Buller, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC. SCAI/ACC i2.
  42. Impact of Clopidogrel Loading Dose on the Safety and Effectiveness of Bivalirudin in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction: The HORIZONS AMI Trial. George Dangas, Giulio Guagliumi, Bernhard Witzenbichler, Deepak Bhatt, Frederick Feit, Magnus Ohman, S. Chiu Wong, Helen Parise, Roxana Mehran, Gregg W. Stone, Columbia University Medical Center/Cardiovascular Research Foundation, New York. SCAI/ACC i2.

back to top

TCT 2008

  1. Bivalirudin Monotherapy Provides Similar One-Year Survival Compared to Heparin plus GP IIb/IIIa Inhibitors Among Diabetic Patients Undergoing Percutaneous Coronary Intervention: Results from the ACUITY Trial. Frederick Feit, Steven V Manoukian, E Magnus Ohman, Michael J Attubato, Roxana Mehran, Derek Chew, Harvey D White, Gregg W Stone. TCT 2008.
  2. The Safety and Effectiveness of Cypher Stent for Bifurcation versus Non-Bifurcation Lesion. Two-Year Follow-Up Analysis From the MATRIX Registry. Adriano Caixeta, Giora Weisz, Roxana Mehran, Michael B Collins, Varinder Singh, Alexandra J Lansky, Susheel Kodali, Theresea Franklin-Bond, Neil Matharoo, Roland Wu, Dorothy Franklin, Kathy Morgan, Gregg W Stone, Jeffrey M Moses, Martin Fahy, Martin Leon, George Dangas. TCT 2008.
  3. Five-Year Cumulative Rates of Clinical Events after Cypher™ Stent Implantation: Insights from a Patient-Level Pooled Analysis of Four Randomized Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents. Adriano Caixeta, Roxana Mehran, Jeffrey W Moses, George Dangas, Helen Parise, Ajay Kirtane, David R Holmes, Charles O'Shaughnessy, Dennis Donohoe, Ronald Caputo, Dean J Kereiakes, David O Williams, Martin B Leon. TCT 2008.
  4. Contrast-Induced Nephropathy Redefined; Impact of Any Acute Kidney Injury on Clinical Outcomes in Patients with ACS undergoing Angiography: Results from the ACUITY Trial. Roxana Mehran, George D Dangas, Giora Weisz, Steven V Manoukian, Antonio Colombo, Jeffrey Moses, Frederick Feit, Stuart Pocock, E Magnus Ohman, A Michael Lincoff, Harvey D White, Alexandra J Lansky, Gregg W Stone. TCT 2008.
  5. Two Year Outcome in Patients with Unprotected Left Main Coronary Artery Stenosis Treated with Drug-Eluting Stent Implantation: Milan and New York Experience. Alaide Chieffo, Roxana Mehran, Damiana Fischella, Valeria Magni, Young Hak Kim, Azeem Latib, Georges Dangas, Matteo Montorfano, Mauro Carlino, Martin B Leon, Jeffrey W Moses, Antonio Colombo. TCT 2008.
  6. Meta-analysis of Drug-eluting Stents in Acute Myocardial Infarction: Results in 23,711 Patients from Randomized Controlled Trials and Registries. Somjot S Brar, Martin B. Leon, Roxana Mehran, Jeffrey W Moses, Gregg W Stone, George D Dangas. TCT 2008.
  7. Relative Prognostic Utility of Different Bleeding Scales Among Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction: The HORIZONS-AMI Trial. Ajay J Kirtane, Roxana Mehran, Helen Parise, Stuart Pocock, Tim Clayton, Bernhard Witzenbichler, Giulio Guagliumi, Jan Peruga, Ran Kornowski, Eugenia Nikolsky, E. Magnus Ohman, Adnan Kastrati, George D. Dangas, Alexandra J. Lansky, Gregg W. Stone. TCT 2008.
  8. Impact of Major Adverse Cardiac Events and Major Bleeding on Overall Mortality in Patients with Acute Myocardial Infarction: Results from the HORIZONS-AMI Trial. Helen Parise, Roxana Mehran, Bernhard Witzenbichler, Giulio Guagliumi, Jan Z Peruga, Bruce R Brodie, Dariusz Dudek, Ran Kornowski, Franz Hartmann, Bernard J Gersh, Stuart J Pocock, George Dangas, S. Chiu Wong, Ajay Kirtane, Alexandra J Lansky, Gregg W Stone. TCT 2008.
  9. Incidence and Clinical Consequence of Acquired Thrombocytopenia Following Antithrombotic Therapies in Patients with Acute Coronary Syndromes: Insights from the ACUITY Trial. Adriano Caixeta, Jiro Aoki, George D Dangas, Roxana Mehran, Jeffrey W Moses, Steven R Steinhubl, Frederick Feit, Harvey D White, E. Magnus Ohman, Steven V Manoukian, Jayne Prats, Gregg W Stone. TCT 2008.
  10. Impact of Baseline Thrombocytopenia on the Treatment of Primary Angioplasty in Acute Myocardial Infarction: The HORIZONS-AMI Trial. Adriano Caixeta, Jiro Aoki, George D Dangas, Roxana Mehran, Bernhard Witzenbicher, Giulio Guagliumi, Jan Z Peruga, Bruce Brodie, Dariusz Dudek, Ran Kornowski, Hartmann Franz, Helen Parise, Gregg W Stone. TCT 2008.
  11. Clinical Impact of Successful Percutaneous Revascularization of Chronic Total Occlusions: 3-Year Follow-up Results from an International Multicenter CTO Registry. Kotaro Obunai, Somjot Brar, Jeffrey W. Moses, Martin B. Leon, Gregg W. Stone, George D. Dangas, Theresa Franklin-Bond, Cosmo Godino, Giorgio Bassanelli, Matteo Montorfano, Mauro Carlino, Alfonso Lelasi, Alaide Chieffo, Antonio Colombo, Roxana Mehran. TCT 2008.
  12. Prognostic Utility of the Baseline White Blood Cell Count in Patients with Acute Coronary Syndromes: The ACUITY trial. Roxana Mehran, Somjot Brar, George Dangas, Damiana Fiscella, Adriano Caixeta, Giora Weisz, LeRoy Rabbani, Konstantinos Sfakianakis, Jena Stent, Jeffrey W Moses, Gregg W Stone. TCT 2008.
  13. Thrombectomy Prior to Stent Implantation in Patients with Visible Thrombus: Is There a Benefit? R Wu, N Verma, M Herscher, L Higginbotham, P Boland, N Dasgupta, D Fiscella, T Franklin-Bond, K Morgan, J Stant, F Esposito, G Piri, L Gaus, S Walter, L Rabbani, G Weisz, S Brar, G Stone, M Leon, J W Moses, G Dangas. TCT 2008.
  14. Real World Safety And Efficacy Of The Janus Tacrolimus-Eluting Stent: Long-Term Clinical Outcome And Angiographic Findings From The Tacrolimus-Eluting Stent (TEST) Registry. Corrado Tamburino, Maria E Di Salvo, Davide Capodanno, Piera Capranzano, Rosario Parisi, Francesca Mirabella, Francesco Scardaci, Gianpaolo Ussia, Alfredo R Galassi, Damiana Fiscella, Roxana Mehran, George Dangas. TCT 2008.
  15. Outcomes Related to Drug-Eluting Stents vs. Bare Metal Stents in Saphenous Vein Graft Intervention: An ACUITY Substudy. Ajay J Kirtane, Roxana Mehran, Somjot S Brar, Martin Fahy, George D Dangas, Frederick Feit, Jeffrey W Moses, Steven Manoukian, Harvey D White, Alexandra J Lansky, Gregg W Stone. TCT 2008.
  16. The Safety of 6-Month versus 12-Month Dual Antiplatelet Therapy in Patients Treated with Zotarolimus-Eluting Stent: A Patient-Level Pooled Analysis of Five ENDEAVOR Randomized Trials. Roxana Mehran, David E Kandzari, Laura Mauri, Adriano Caixeta, George Dangas, Manuela Negoita, Martin B Leon. TCT 2008.
  17. Implantation of Drug-Eluting Stents Compared to Bare Metal Stents After Intracoronary Thrombectomy. Roland S Wu, P Boland, L Higginbotham, N Dasgupta, D Fiscela, K Sfakianakis, T Franklin-Bond, K Morgan, J Stant, F Esposito, Piri G, M Reilly, S Duru, L Rabbani, S Brar, G Stone, M Leon, J W Moses, G Dangas, R Mehran. TCT 2008.
  18. Drug-Eluting Stent versus Bare Metal Stent Use: Meta-Analysis of Randomized Trials and Observational Studies. Ajay J Kirtane, Anuj Gupta, Srinivas Iyengar, Roxana Mehran, Jeffrey W Moses, Martin B Leon, Robert Applegate, Edward Hannan, Kishore Harjai, Michael Racz, Lisette Okkels Jensen, Seung-Jung Park, Raphael Perry, Francesco Saia, Charles Simonton, Jack V Tu, Ron Waksman, Gregg W Stone. TCT 2008.
  19. Impact of Direct Stenting on The Outcomes of Primary Angioplasty in Acute Myocardial Infarction: The HORIZONS-AMI Trial. Martin Möckel, Jörn O. Vollert, Alexandra Lansky, Bernhard Witzenbichler, Giulio Guagliumi, Jan Z. Peruga, Bruce R. Brodie, Ran Kornowski, Dariusz Dudek, Carol Moore, Helen Parise, Roxana Mehran, Gregg W Stone. TCT 2008.
  20. Do Vascular Closure Devices Reduce Bleeding Complications After Primary PCI in ST-Segment Elevation Myocardial Infarction? The HORIZONS-AMI Trial. Bernhard Witzenbichler, Giulio Guagliumi, Jan Z Peruga, Bruce R. Brodie, Dariusz Dudek, Ran Kornowski, Franz Hartmann, Bernard J. Gersh, Alexandra J. Lansky, Helen Parise, Roxana Mehran, Gregg W. Stone. TCT 2008.
  21. Contrast-Induced Nephropathy is Frequent and is a Powerful Independent Predictor of Morbidity and Mortality In Patients With Acute Myocardial Infarction Treated With Primary PCI: The HORIZONS-AMI trial. Giora Weisz, Roxana Mehran, LeRoy Rabbani, Ran Kornowski, Franz Hartmann, S. Chiu Wong, Alexandra Lansky, Helen Parise, Gregg W Stone. TCT 2008.
  22. Gender Bias in the Diagnosis, Treatment, and Interpretation of CHD Symptoms: Two Experimental Studies with Internists and Family Physicians. Gabrielle R. Chiaramonte, Ronald Friend, Arnold S. Jaffe, Alexandra J. Lansky, Gil Weitzman, Jeffrey S. Trilling, Susan Evans. TCT 2008.
  23. Intravascular Ultrasound Comparison of Retrograde vs Antegrade Approach to Percutaneous Intervention for Chronic Total Coronary Occlusion. Kenichi Tsujita, Akiko Maehara, Gary S. Mintz, Takashi Kubo, Hiroshi Doi, Celia Castellanos, Jian Liu, Junqing Yang, Carlos Oviedo, Gregg W. Stone, Martin B. Leon, Jeffrey W. Moses, Masahiko Ochiai. TCT 2008.
  24. Long Term Safety Results From the Endeavor Program: Four-Year Follow-up. Laura Mauri, Donald E Cutlip, Martin B Leon, David E Kandzari, William Wijns, Jean Fajadet, Joseph M Massaro, Wei Guo, Ian T Meredith. TCT 2008.
  25. Directional Sirolimus Biodegradable Abluminal Coating and Anti-CD34 Surface Modification: Early Animal Data on Vascular Healing and Restenosis. Juan F Granada, Carlos L Alviar, Martin B Leon, Greg L Kaluza, Armando Tellez, David Wallace-Bradley, Stephen Rowland, Sherry P Parker, Frank Kolodgie, Gaku Nakazawa, Renu Virmani. TCT 2008.
  26. The Impact of Non-Stent Related Progression of Underlying Coronary Artery Disease on Late Clinical Outcomes after Paclitaxel-Eluting Stents. Dominic J. Allocco, Keith D. Dawkins, Donald S. Baim, Martin B. Leon. TCT 2008.
  27. Comparison of Vascular Response to Zotarolimus-Eluting Stent Versus Paclitaxel-Eluting Stent Implantation: IVUS Results From the ENDEAVOR IV Trial. Katsuhisa Waseda, Akiyoshi Miyazawa, Takao Hasegawa, Ichizo Tsujino, Ryota Sakurai, Junya Ako, Paul G Yock, Yasuhiro Honda, David E Kandzari, Martin B Leon, Peter J Fitzgerald, The ENDEAVOR IV Trial investigators. TCT 2008.
  28. First-in-Man Clinical and Angiographic Outcomes Using the Cappella Sideguard Self-Expanding Sidebranch Stent in Patients with Bifurcation Coronary Lesions. Eberhard Grube, Karl E Hauptmann, Georg Nickenig, William Wijns, Jozef Dens, Joachim Schofer, Heinz Büttner, Stefan Verheye, Martin B Leon. TCT 2008.
  29. Spatial Distribution Of Fibroatheromas In The Left Main Bifurcation, A Virtual Histology Assessment. Carlos Oviedo, Akiko Maehara, Gary S. Mintz, Damiana Fiscella, Kenichi Tsujita, Hiroshi Doi, Takashi Kubo, Jian Liu, Junqing Yang, Rasha Aaskar, Lokesh Dani, Sinan Biro, Jeffrey W. Moses, Martin B. Leon, Gregg W. Stone. TCT 2008.
  30. First-in-Man IVUS Findings Using the Cappella Sideguard Self-Expanding Sidebranch Stent in Patients with Coronary Bifurcation Lesions. Hiroshi Doi, Akiko Maehara, Gary S Mintz, Lokesh Dani, Karl E Hauptmann, Eberhard Grube, Martin B Leon. TCT 2008.
  31. Does Presentation at a Non PCI Facility Requiring Transfer Worsen Prognosis in Patients With Acute MI Undergoing Primary Angioplasty? The HORIZONS-AMI Trial. Jochen Wöhrle, Bernhard Witzenbichler, Giulio Guagliumi, Jan Z Peruga, Bruce R Brodie, Dariusz Dudek, Ran Kornowski, Franz Hartmann, Bernard J Gersh, Helen Parise, Roxana Mehran, Gregg W Stone. TCT 2008.
  32. Upstream Bivalirudin Monotherapy Results in Similar One Year Survival as Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients With Non-ST-Elevation Acute Coronary Syndromes Undergoing Bypass Graft Surgery: A Report From the ACUITY Trial. Ramin Ebrahimi, Steven V Manoukian, Frederick Feit, A Michael Lincoff, Cornelius Dyke, Bernard Gersh, Roxana Mehran, Jeffrey W Moses, Gregg W Stone. TCT 2008.
  33. Durable Long Term Outcomes Of A Dedicated Drug Eluting Bifurcation Lesion Stent: 1-3 Year Clinical Outcomes From The Axxess Plus Trial. Eberhard Grube, Ralf Mueller, Lutz Buellesfeld, Stefan Verheye, Franz Neumann, Alexander Abizaid, Dougal McClean, Roxana Mehran, Brett Trauthen. TCT 2008.
  34. Comparative Between Virtual Histology Intravascular ultrasound and Echoplaque MIB in autopsied coronary arteries: Validation of DICOM-Based Ultrasound Signal Intensity. Sang-Wook Kim, Gary S Mintz, Wang-Soo Lee, Gi-Hwan Kim, Kyung-Sook Park, Eun-Young Kim, Gi-Woo Seo, Kwang-Je Lee, Tae-Ho Kim, Chee-Jung Kim, Wang-Seong Ryu, Neil J Weissman. TCT 2008.
  35. Stent Expansion and Neointimal Hyperplasia after Sirolimus-eluting or Paclitaxel-eluting Stent Implantation in Diabetic Patients. Rasmus Egede, Lisette Okkels Jensen, Gary S. Mintz, Michael Maeng, Evald Hoej Christiansen, Knud Noerregaard Hansen, Anders Galloe, Henning Kelbaek, Jens Flensted Lassen, Leif Thuesen, Per Thayssen. TCT 2008.
  36. The Decreased Expression of Nogo-B in Atherosclerotic Progression; Comparative analysis with Virtual Histology Intravascular Ultrasound Analysis. Wang-Soo Lee, Sang-Wook Kim, Gary S Mintz, Kyung-Hun Lee, Kwang-Je Lee, Tae-Ho Kim, Chee-Jeong Kim, Wang-Seong Ryu. TCT 2008.
  37. Vascular Responses at Proximal and Distal Edges of Sirolimus-Eluting or Paclitaxel-Eluting Stent in Diabetic Patients. A Randomized Serial Intravascular Ultrasound Analysis from the DiabeDES II Trial. Lisette Okkels Jensen, Michael Maeng, Gary S Mintz, Evald Hoej Christiansen, Knud N Hansen, Anders Galloe, Henning Kelbaek, Jens F Lassen, Leif Thuesen, Per Thayssen. TCT 2008.
  38. Plaque Progression: Pathology and Virtual Histology Intravascular Ultrasound Comparison study. Wang-Soo Lee, Sang-Wook Kim, Gary S Mintz, Kyung-Hun Lee, Kwang-Je Lee, Tae-Ho Kim, Chee-Jeong Kim, Wang-Seong Ryu. TCT 2008.
  39. Near-Infrared Spectroscopic Measurement of Lipid-Core Coronary Plaque Length: Implications for Complete Lesion Coverage in Patients Undergoing Stenting. Simon R Dixon, Philippe L'Allier, Jeffrey W Moses, John L Petersen, Donald E Cutlip, Cindy L Grines, Giora Weisz, Michael J Hendricks, Stephen T Sum, James E Muller, Mitchell W Krucoff, Jean-Claude Tardif, Sergio Waxman, Gregg W Stone, James A Goldstein. TCT 2008.
  40. Initial Clinical Experience Using an Ostial Stent Positioning System (Ostial ProTM) for the Accurate Placement of Stents in the Treatment of Coronary Aorto-Ostial Lesions. Tim A Fischell, Frank S Saltiel, Malcolm T Foster, III, Shing-Chiu Wong, Jeffrey Moses. TCT 2008.
  41. Relationship of the Near Infrared Lipid Core Burden Index in Coronary Segments with Traditional Risk Factors in Patients Undergoing PCI. John L Peterson, Giora Weisz, Simon R Dixon, Philippe L L'Allier, Jeffrey W Moses, Donald E Cutlip, Sean P Madden, Michael J Hendricks, Stephen T Sum, James E Muller, Jean-Claude Tardif, Sergio Waxman, Gregg W Stone, James A Goldstein, Mitchell W Krucoff. TCT 2008.
  42. IVUS Analysis in the SPIRIT III Japan Treated with XIENCETM V Everolimus-Eluting Stent Compared to the SPIRIT III US Arm. Takao Shimohama, Hiromasa Otake, Junya Ako, Masao Yamasaki, Ichizo Tsujino, Katsuhisa Waseda, Takao Hasegawa, Ryota Sakurai, Daisaku Nakatani, Hyeonsoo Chang, Paul G. Yock, Yasuhiro Honda, Hajime Kusano, Krishnankutty Sudhir, Shigeru Saito, Gregg W. Stone, Peter J. Fitzgerald. TCT 2008.
  43. Clinical and Angiographic Results of Small Vessel Stenting from the SPIRIT III Randomized Trial: A Comparison of the 2.5 mm Everolimus-Eluting XIENCE and Paclitaxil-Eluting TAXUS Stents. James Hermiller, Todd Fergus, Wesley Pierson, Xiaolu Su, Roseann White, Poornima Sood, Krishnankutty Sudhir, Gregg Stone. TCT 2008.
  44. Angiographic and clinical outcomes from the XIENCETM V 4.0mm Registry arm of the SIII trial. Paul C. Gordon, Steven B. Weinsier, Xiaolu Su, Rosann white, Julie Doostzadeh, Sherry Cao, Poornima sood, Krishna Sudhir, Gregg W. Stone. TCT 2008.
  45. Vascular Response to Overlapping Everolimus-eluting stents: Comparison with Paclitaxel-eluting Stents. Hiromasa Otake, Junya Ako, Masao Yamasaki, Ichizo Tsujino, Takao Shimohama, Takao Hasegawa, Ryota Sakurai, Katsuhisa Waseda, Paul G Yock, Yasuhiro Honda, Krishnankutty Sudhir, Gregg W Stone, Peter J Fitzgerald. TCT 2008.

back to top

 

CRF Websites

TCTMD.com
The source for interventional cardiovascular news & education.

HeartHealthyWomen.org
The online source for information on heart disease in women.